Literature DB >> 29241815

Litigation in orthopedic surgery: What can we do to prevent it? Systematic analysis of 126 legal actions involving four university hospitals in France.

J Mouton1, R Gauthé2, M Ould-Slimane2, S Bertiaux3, S Putman4, F Dujardin2.   

Abstract

INTRODUCTION: Orthopedic surgery produces 20% of medical malpractice claims. However only a few studies have examined the reasons for and consequences of these disputes, and they have usually been limited to a single hospital. This led us to perform a retrospective analysis of the claims at four teaching hospitals in northwestern France. The goals were (1) to describe the circumstances that led to these claims and recommend ways to prevent them, and (2) to describe the conduct of the proceedings and their financial and social outcomes. HYPOTHESIS: A systematic analysis of litigation cases will provide accurate information on the circumstances leading to these claims.
METHODS: The study included 126 disputes settled between 2000 and 2010 and related to orthopedic or trauma care given at one of four teaching hospitals in northwestern France. The method of recourse, grounds of the complaint, type of surgical procedure, expert findings and amount of the award were systematically analyzed.
RESULTS: Of these 126 cases, 54 (43%) of them were submitted to the French CRCI (regional conciliation and compensation commission), 48 (39%) to the French administrative courts and 51 (41%) were settled amicably. Multiple methods of recourse were used in 21% of cases (n=27/126). The average length of administrative court proceedings was 36.7±27 months [4-102], which was significantly longer than the CRCI proceedings (22.7±17.9 months [3-80]) or out-of-court settlement (23.7±21.5 months [0-52]) (p<0.0001). Damages were sought for medical error or treatment-related risk in 67.5% of the complaints (n=85/126), and for failure to inform in 15.8% of cases (n=20/126). There was a suspected surgical site infection in 79.3% of cases (n=100/126). There were multiple grounds for complaint in 68.3% of cases (n=86/126). Poor communication between the physician and patient was identified in 26.2% of cases (n=33/126). Damages were awarded in 25% of cases (n=31/126), with an average award of €58,303±€91,601 [0-357,970].
CONCLUSION: The primary grounds for legal action are infection-related complications combined with a deterioration in the doctor-patient relationship. Disputes could be prevented by continuing efforts to combat hospital-acquired infections and providing better communications training. LEVEL OF PROOF: IV (retrospective study).
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Compensation; Judiciary; Litigation; Traumatology

Mesh:

Year:  2017        PMID: 29241815     DOI: 10.1016/j.otsr.2017.11.002

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  4 in total

1.  Antibiotic Use in Hand Surgery: Surgeon Decision Making and Adherence to Available Evidence.

Authors:  John C Dunn; Kenneth R Means; Sameer Desale; Aviram M Giladi
Journal:  Hand (N Y)       Date:  2018-11-22

2.  Litigations in orthopedics and trauma surgery: reasons, dynamics, and profiles.

Authors:  Martin Gathen; M Jaenisch; F Fuchs; L Weinhold; M Schmid; S Koob; D C Wirtz; M D Wimmer
Journal:  Arch Orthop Trauma Surg       Date:  2021-05-27       Impact factor: 3.067

3.  Interpersonal factors contributing to tension in the Chinese doctor-patient-family relationship: a qualitative study in Hunan Province.

Authors:  Siyu Xiao; Lixuan Wang; E Jennifer Edelman; Kaveh Khoshnood
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

4.  Why Are Patients Unhappy with Their Healthcare? A Romanian Physicians' Perspective.

Authors:  Bianca Hanganu; Irina Smaranda Manoilescu; Cristian Paparau; Laura Gheuca-Solovastru; Camelia Liana Buhas; Andreea Silvana Szalontay; Beatrice Gabriela Ioan
Journal:  Int J Environ Res Public Health       Date:  2022-08-02       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.